Acotec Scientific Holdings Limited

SEHK:6669 Stock Report

Market Cap: HK$2.0b

Acotec Scientific Holdings Past Earnings Performance

Past criteria checks 1/6

Acotec Scientific Holdings has been growing earnings at an average annual rate of 52.8%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 22.1% per year. Acotec Scientific Holdings's return on equity is 2.4%, and it has net margins of 6.1%.

Key information

52.8%

Earnings growth rate

51.3%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate22.1%
Return on equity2.4%
Net Margin6.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued

Mar 21
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued

We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth

Nov 17
We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth

Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price

Oct 20
Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price

Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward

Sep 24
Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

Jul 01
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

Revenue & Expenses Breakdown

How Acotec Scientific Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:6669 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2452332181201
31 Mar 2449823181195
31 Dec 2347414181190
30 Sep 2346938184193
30 Jun 2346361186197
31 Mar 2342966173190
31 Dec 2239670161184
30 Sep 2236717140170
30 Jun 22339-35120157
31 Mar 22338-24109144
31 Dec 21304-79116141
30 Sep 21285-76126136
30 Jun 21266-74136131
31 Mar 21228-81129113
31 Dec 20194-4410683
31 Dec 19125235725

Quality Earnings: 6669 has a high level of non-cash earnings.

Growing Profit Margin: 6669's current net profit margins (6.1%) are lower than last year (13.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6669 has become profitable over the past 5 years, growing earnings by 52.8% per year.

Accelerating Growth: 6669's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6669 had negative earnings growth (-47.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-4.3%).


Return on Equity

High ROE: 6669's Return on Equity (2.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 20:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Acotec Scientific Holdings Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo YuChina International Capital Corporation Limited
Yuan GaoChina International Capital Corporation Limited
Yiling ChenGuosen Securities Co., Ltd.